We are live on ! Find out more
OGEN icon

Oragenics
OGEN

17 hedge funds and large institutions have $6.63M invested in Oragenics in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital inflows, than outflows

Capital inflows: $1.09M | Capital outflows: $994K

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

0.19% less ownership

Funds ownership: 8.32% → 8.13% (-0.19%)

26% less funds holding

Funds holding: 23 → 17 (-6)

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

Holders
17
Holders Change
-6
Holders Change %
-26.09%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
3
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$374K
2
State Street
State Street
Massachusetts
+$332K
3
Renaissance Technologies
Renaissance Technologies
New York
+$184K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$142K
5
Virtu Financial
Virtu Financial
New York
+$31.6K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$336K
2
Bridgeway Capital Management
Bridgeway Capital Management
Texas
-$225K
3
BlackRock
BlackRock
New York
-$201K
4
Private Wealth Advisors (California)
Private Wealth Advisors (California)
California
-$52K
5
GSA Capital Partners
GSA Capital Partners
United Kingdom
-$44K

OGEN Hedge Fund Activity: Q2 2021 in Review

17 of the 5,769 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q2 2021, worth a combined $6.63M — down 20% from $8.27M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of OGEN and 4 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 3 added.

The largest buyer was Vanguard Group, adding an estimated $374K. The largest seller was Citadel Advisors, exiting entirely with an estimated $336K sold.

  • 17 institutional investors held Oragenics (OGEN) as of Q2 2021, down from 23 in Q1 2021.
  • Funds reported $6.63M of Oragenics stock for Q2 2021, down 20% quarter-over-quarter.
  • 4 funds opened new Oragenics positions in Q2 2021 and 10 closed out, a net change of -6 holders.
  • The largest Oragenics buyer in Q2 2021 was Vanguard Group, an estimated $374K added.
  • The largest Oragenics seller in Q2 2021 was Citadel Advisors, an estimated $336K sold.

Based on aggregated 13F filings for Q2 2021.